Health Tourism and Artificial Saliva Markets Forecast Strong Growth to 2033

A market research report projects the global health tourism market to expand from about $75.27 billion in 2025 to roughly $1.14 trillion by 2033, representing a compound annual growth rate (CAGR) of 40.4%. The analysis highlights demand for affordable, advanced medical services in destinations such as Thailand, India, Malaysia and Singapore, and lists major industry players including Apollo Hospitals, Bumrungrad International Hospital, Fortis Healthcare and others.

A separate forecast for the artificial saliva market estimates its value at $1.42 billion in 2024, rising to $4.06 billion by 2032 with a CAGR of 14.0%. Growth is driven by increasing prevalence of dry‑mouth conditions and greater use in hospitals, clinics and home‑care settings. Leading manufacturers cited are GlaxoSmithKline plc, Cipla, Sun Pharmaceutical Industries and several specialty firms.